Editor's Note: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR

Martin L. Sos; Mirjam Koker; Barbara A. Weir; Stefanie Heynck; Rosalia Rabinovsky; Thomas Zander; Jens M. Seeger; Jonathan Weiss; Florian Fischer; Peter Frommolt; Kathrin Michel; Martin Peifer; Craig Mermel; Luc Girard; Michael Peyton; Adi F Gazdar; John D. Minna; Levi A. Garraway; Hamid Kashkar; William Pao; Matthew Meyerson; Roman K. Thomas

doi:10.1158/0008-5472.CAN-24-5044

Editor's Note: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR

Martin L. Sos, Mirjam Koker, Barbara A. Weir, Stefanie Heynck, Rosalia Rabinovsky, Thomas Zander, Jens M. Seeger, Jonathan Weiss, Florian Fischer, Peter Frommolt, Kathrin Michel, Martin Peifer, Craig Mermel, Luc Girard, Michael Peyton, Adi F Gazdar, John D. Minna, Levi A. Garraway, Hamid Kashkar, William PaoMatthew Meyerson, Roman K. Thomas

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1003
Number of pages	1
Journal	Cancer research
Volume	85
Issue number	5
DOIs	https://doi.org/10.1158/0008-5472.CAN-24-5044
State	Published - Mar 2025

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1158/0008-5472.CAN-24-5044

Cite this

Sos, M. L., Koker, M., Weir, B. A., Heynck, S., Rabinovsky, R., Zander, T., Seeger, J. M., Weiss, J., Fischer, F., Frommolt, P., Michel, K., Peifer, M., Mermel, C., Girard, L., Peyton, M., Gazdar, A. F., Minna, J. D., Garraway, L. A., Kashkar, H., ... Thomas, R. K. (2025). Editor's Note: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR. Cancer research, 85(5), 1003. https://doi.org/10.1158/0008-5472.CAN-24-5044

Sos, ML, Koker, M, Weir, BA, Heynck, S, Rabinovsky, R, Zander, T, Seeger, JM, Weiss, J, Fischer, F, Frommolt, P, Michel, K, Peifer, M, Mermel, C, Girard, L, Peyton, M, Gazdar, AF, Minna, JD, Garraway, LA, Kashkar, H, Pao, W, Meyerson, M & Thomas, RK 2025, 'Editor's Note: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR', Cancer research, vol. 85, no. 5, pp. 1003. https://doi.org/10.1158/0008-5472.CAN-24-5044

@article{6fa2d333d4e94cc5a6b2ed41fdd0e21f,

title = "Editor's Note: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR",

author = "Sos, {Martin L.} and Mirjam Koker and Weir, {Barbara A.} and Stefanie Heynck and Rosalia Rabinovsky and Thomas Zander and Seeger, {Jens M.} and Jonathan Weiss and Florian Fischer and Peter Frommolt and Kathrin Michel and Martin Peifer and Craig Mermel and Luc Girard and Michael Peyton and Gazdar, {Adi F} and Minna, {John D.} and Garraway, {Levi A.} and Hamid Kashkar and William Pao and Matthew Meyerson and Thomas, {Roman K.}",

year = "2025",

month = mar,

doi = "10.1158/0008-5472.CAN-24-5044",

language = "English (US)",

volume = "85",

pages = "1003",

journal = "Cancer research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "5",

}

TY - JOUR

T1 - Editor's Note

T2 - PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR

AU - Sos, Martin L.

AU - Koker, Mirjam

AU - Weir, Barbara A.

AU - Heynck, Stefanie

AU - Rabinovsky, Rosalia

AU - Zander, Thomas

AU - Seeger, Jens M.

AU - Weiss, Jonathan

AU - Fischer, Florian

AU - Frommolt, Peter

AU - Michel, Kathrin

AU - Peifer, Martin

AU - Mermel, Craig

AU - Girard, Luc

AU - Peyton, Michael

AU - Gazdar, Adi F

AU - Minna, John D.

AU - Garraway, Levi A.

AU - Kashkar, Hamid

AU - Pao, William

AU - Meyerson, Matthew

AU - Thomas, Roman K.

PY - 2025/3

Y1 - 2025/3

UR - http://www.scopus.com/inward/record.url?scp=85219745124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85219745124&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-24-5044

DO - 10.1158/0008-5472.CAN-24-5044

M3 - Editorial

C2 - 40025966

AN - SCOPUS:85219745124

SN - 0008-5472

VL - 85

SP - 1003

JO - Cancer research

JF - Cancer research

IS - 5

ER -

Editor's Note: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this